Renowned Cancer Surgeon Norman Wolmark Joins UPMC to Direct Clinical Trials

Investigator profile TrialsiteN

Prominent surgeon and cancer investigator Norman Wolmark has left Allegheny Health Network to lead the University of Pittsburgh and the UPMC Hillman Cancer Center.  Dr. Wolmark will now become professor of surgery at the University of Pittsburgh School of Medicine as well as director of the National Cancer Institute cooperative group clinical trials.

Dr. Wolmark will still retain his role as chairman of the National Surgical Adjuvant Breast and Bowel Project (NSABP, an independent clinical trials cooperative group he has led since 1994), reports Jill Daily of the Pittsburgh Post-Gazette.

Ms. Daily from the Post-Gazette reports that in a public statement Dr. Wolmark noted “I look forward to applying the acclaimed expertise in precision medicine and genomic research currently available at the University of Pittsburgh to the clinical trials of the NSABP Foundation.”

Hillman Center director Dr. Robert Ferris explained that UPMC is on the move, seeking to expand their clinical research programs with Dr. Wolmark at the helm.

Decades ago, Dr. Wolmark helped manage early clinical trials with noted breast cancer surgeon Dr. Bernard Fisher, who was NSAPB chairman from 1967 to 1994. Dr. Wolmark left Pitt and his work at Montefiore Hospital to direct the Allegheny Cancer Center and director of surgical oncology at Allegheny General Hospital. Most recently, he was medical director of Breast Surgical Oncology, Cancer Research and Clinical Trials at Allegheny Health Network.